Effect of denosumab on bone mineral density (BMD) in women with breast cancer (BC) and men with prostate cancer (PC) undergoing hormone ablation therapy

Matthew R. Smith,Georgiana K. Ellis,Fred Saad,Teuvo L.J. Tammela,Henry G. Bone,Blair Egerdie,C Ke,Susie Jun,Roger Dansey,Carsten Goessl

Effect of denosumab on bone mineral density (BMD) in women with breast cancer (BC) and men with prostate cancer (PC) undergoing hormone ablation therapy

2016

Matthew R. Smith
Georgiana K. Ellis
Fred Saad
Teuvo L.J. Tammela
Henry G. Bone
Blair Egerdie
C Ke
Susie Jun
Roger Dansey
Carsten Goessl

9520 Background: Hormone ablation therapies, including adjuvant aromatase inhibitor (AI) therapy and androgen deprivation therapy (ADT), improve recurrence-free survival in patients (pts) with BC a...

Keywords:

Breast cancer
Bone mineral
Pathology
Denosumab
Oncology
Prostate cancer
Aromatase inhibitor
Ablation
Hormone
Androgen deprivation therapy
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations